Odyssean LLC’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.14M Buy
22,464
+10,814
+93% +$2.35M 0.48% 92
2026
Q2
$2.85M Buy
11,650
+2,377
+26% +$515K 0.46% 73
2026
Q1
$1.57M Buy
9,273
+4,290
+86% +$741K 0.57% 8
2025
Q4
$910K Buy
+4,983
New +$696K 0.65% 1

Other funds holding AXSM

Odyssean LLC's AXSM Position: Q3 2026 in Review

Odyssean LLC increased its Axsome Therapeutics (AXSM) stake by 93% in Q3 2026, buying an estimated $2.35M and bringing the position to 22,464 shares worth $4.14M. The position accounts for 0.48% of the portfolio, ranked #92.

Odyssean LLC first reported a position in AXSM in Q4 2025 and has held it in 4 quarters since. 466 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • Odyssean LLC held 22,464 shares of Axsome Therapeutics worth $4.14M as of Q3 2026.
  • Odyssean LLC bought 10,814 Axsome Therapeutics shares in Q3 2026, an estimated $2.35M.
  • Axsome Therapeutics made up 0.48% of Odyssean LLC's portfolio in Q3 2026, its #92 holding.
  • Odyssean LLC first reported a position in Axsome Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • 466 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.